The Drug Repurposing Hub: a next-generation drug library and information resource
CORRESPONDENCE (tool compounds are valuable for achieving the target redundancy
needed to differentiate on-target from off-target activities of clinical drugs being considered …
needed to differentiate on-target from off-target activities of clinical drugs being considered …
The Drug Repurposing Hub: a next-generation drug library and information resource.
SM Corsello, JA Bittker, Z Liu, J Gould… - Nature …, 2017 - europepmc.org
Drug repurposing, the application of an existing therapeutic to a new disease indication,
holds the promise of rapid clinical impact at a lower cost than de novo drug development. To …
holds the promise of rapid clinical impact at a lower cost than de novo drug development. To …
The Drug Repurposing Hub: a next-generation drug library and information resource
SM Corsello, JA Bittker, Z Liu, J Gould… - Nature …, 2017 - pubmed.ncbi.nlm.nih.gov
The Drug Repurposing Hub: a next-generation drug library and information resource The Drug
Repurposing Hub: a next-generation drug library and information resource Nat Med. 2017 Apr …
Repurposing Hub: a next-generation drug library and information resource Nat Med. 2017 Apr …
The Drug Repurposing Hub: a next-generation drug library and information resource
SM Corsello, JA Bittker, Z Liu, J Gould, P McCarren… - Nature Medicine, 2017 - go.gale.com
Drug repurposing, the application of an existing therapeutic to a new disease indication,
holds promise of rapid clinical impact at a lower cost than de novo drug development. So far …
holds promise of rapid clinical impact at a lower cost than de novo drug development. So far …
[PDF][PDF] The Drug Repurposing Hub: a next-generation drug library and information resource
SM Corsello, JA Bittker, Z Liu, J Gould, P McCarren… - Nat Med, 2017 - academia.edu
Drug repurposing, the application of an existing therapeutic to a new disease indication,
holds the promise of rapid clinical impact at a lower cost than de novo drug development. To …
holds the promise of rapid clinical impact at a lower cost than de novo drug development. To …
[HTML][HTML] The Drug Repurposing Hub: a next-generation drug library and information resource
SM Corsello, JA Bittker, Z Liu, J Gould… - Nature …, 2017 - ncbi.nlm.nih.gov
Drug repurposing, the application of an existing therapeutic to a new disease indication,
holds the promise of rapid clinical impact at a lower cost than de novo drug development. To …
holds the promise of rapid clinical impact at a lower cost than de novo drug development. To …
[引用][C] The Drug Repurposing Hub: a next-generation drug library and information resource
SM Corsello, JA Bittker, Z Liu, J Gould, P McCarren… - Nature Medicine, 2017 - cir.nii.ac.jp
The Drug Repurposing Hub: a next-generation drug library and information resource.
SM Corsello, JA Bittker, Z Liu, J Gould… - Nature …, 2017 - europepmc.org
Drug repurposing, the application of an existing therapeutic to a new disease indication,
holds the promise of rapid clinical impact at a lower cost than de novo drug development. To …
holds the promise of rapid clinical impact at a lower cost than de novo drug development. To …